83
Growth Score in past quarter
pts
Heat Score 83 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
160739
PRUNUS Therapeutics is a preclinical stage immuno-oncology startup focusing on innovative small molecules.
- Nobu Ueki: CEO and Founder
About the Company
PRUNUS Therapeutics is a preclinical stage immuno-oncology startup. PRUNUS discovers and develops innovative therapeutics for the human and animal healthcare. PRUNUS’ main platform focuses on small molecules' advantages over high-cost biologics and engineered cells for cancer immunotherapy.